Related Experiment Video

Updated: Aug 8, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

Healthy children with invasive community-acquired methicillin-resistant Staphylococcus aureus infections

Curt Stankovic1, Prashant V Mahajan

  • 1Carman and Ann Adams Department of Pediatrics, Children's Hospital of Michigan and Wayne State University School of Medicine, Detroit, MI 48201, USA. cstankov@dmc.org

Pediatric Emergency Care
|May 23, 2006
PubMed

Insights

Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infections are rising in children. This study details two unusual cases of invasive CA-MRSA in previously healthy pediatric patients, highlighting a potential shift in infection patterns.

Area of Science:

  • Pediatric infectious diseases
  • Bacterial pathogenesis
  • Public health microbiology

Background:

  • Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) is increasingly prevalent in pediatric populations.
  • Most CA-MRSA infections present as uncomplicated skin and soft tissue infections treatable with oral antibiotics.
  • Recent trends suggest a rise in invasive CA-MRSA infections, even in children without traditional risk factors.

Observation:

  • Two pediatric patients with no prior risk factors developed invasive CA-MRSA infections.
  • These cases represent atypical presentations of CA-MRSA in previously healthy children.
  • The infections observed were severe, indicating a potential for life-threatening outcomes.

Findings:

  • Invasive CA-MRSA can occur in previously healthy children without identifiable risk factors.
  • Atypical presentations of CA-MRSA infections in pediatrics are emerging.
  • These findings challenge the current understanding of CA-MRSA epidemiology in children.

Implications:

  • Clinicians should maintain a high index of suspicion for invasive CA-MRSA in children, even those without risk factors.
  • Further research is needed to understand the changing epidemiology and virulence of CA-MRSA strains in pediatric populations.
  • Early recognition and appropriate management are crucial for improving outcomes in severe CA-MRSA infections.

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...